Standout Papers

The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic 2020 2026 2022 2024382
  1. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic (2020)
    Leiluo Geng, Karen S.L. Lam et al. Nature Reviews Endocrinology

Immediate Impact

3 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Metabolic dysfunction-associated steatotic liver disease in adults
2025 Standout
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
1 intermediate paper

Works of Leiluo Geng being referenced

The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
2020 Standout
The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity
2017

Author Peers

Author Last Decade Papers Cites
Leiluo Geng 479 263 65 238 13 834
Cynthia T. Luk 264 191 55 241 26 652
Nadine Watson 386 301 87 270 9 952
Z. Li 388 308 36 315 14 917
Antonia Sassmann 366 309 38 116 10 709
Michaela Keuper 386 335 45 290 25 764
Güneş Parlakgül 485 299 37 295 16 979
Adam J. Bree 340 268 95 138 10 869
Audrey Noguchi 391 278 60 117 25 927
Hak Joo Lee 361 192 48 120 19 805
Xiaoban Xin 385 288 31 341 13 892

All Works

Loading papers...

Rankless by CCL
2026